Teladoc Health Free Cash Flow 2014-2023 | TDOC

Teladoc Health free cash flow from 2014 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Teladoc Health Annual Free Cash Flow
2023 193.67
2022 16.53
2021 130.06
2020 -79.55
2019 18.97
2018 -7.74
2017 -39.96
2016 -55.29
2015 -55.00
2014 -13.09
2013 -7.35
Teladoc Health Quarterly Free Cash Flow
2023-12-31 193.67
2023-09-30 100.10
2023-06-30 32.14
2023-03-31 -32.47
2022-12-31 16.53
2022-09-30 4.87
2022-06-30 -14.95
2022-03-31 -62.58
2021-12-31 130.06
2021-09-30 69.77
2021-06-30 8.28
2021-03-31 -31.29
2020-12-31 -79.55
2020-09-30 44.04
2020-06-30 21.14
2020-03-31 -9.25
2019-12-31 18.97
2019-09-30 4.25
2019-06-30 -5.96
2019-03-31 -9.56
2018-12-31 -7.74
2018-09-30 -7.33
2018-06-30 -15.42
2018-03-31 -14.90
2017-12-31 -39.96
2017-09-30 -30.68
2017-06-30 -17.01
2017-03-31 -13.28
2016-12-31 -55.29
2016-09-30 -46.31
2016-06-30 -30.37
2016-03-31 -17.84
2015-12-31 -55.00
2015-09-30 -41.03
2015-06-30 -21.91
2015-03-31 -11.14
2014-12-31 -13.09
2014-09-30 -8.31
2014-06-30 -6.06
2014-03-31 -2.60
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $2.232B $2.602B
Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $122.212B 15.32
Cencora (COR) United States $47.337B 18.89
ICON (ICLR) Ireland $24.074B 23.75
DiDi Global (DIDIY) China $22.638B 0.00
Avantor (AVTR) United States $16.482B 22.71
CochLear (CHEOY) $13.356B 0.00
Viatris (VTRS) United States $13.340B 3.81
Revvity (RVTY) United States $12.276B 21.37
EUROFINS SCIENT (ERFSF) Luxembourg $12.132B 0.00
Charles River Laboratories (CRL) United States $11.721B 21.37
Medpace Holdings (MEDP) United States $11.598B 42.15
Solventum (SOLV) United States $11.046B 0.00
Natera (NTRA) United States $10.540B 0.00
Amplifon S.p.A (AMFPF) Italy $7.290B 37.01
HealthEquity (HQY) United States $6.851B 51.19
Bausch + Lomb (BLCO) Canada $5.032B 19.35
Doximity (DOCS) United States $4.630B 34.47
Organon (OGN) United States $4.566B 4.42
Sotera Health (SHC) United States $3.085B 15.14
Progyny (PGNY) United States $3.064B 51.42
Surgery Partners (SGRY) United States $2.965B 27.55
Life Times (LTH) United States $2.756B 30.46
GoodRx Holdings (GDRX) United States $2.658B 134.60
Premier (PINC) United States $2.491B 9.12
Agilon Health (AGL) United States $2.203B 0.00
AMN Healthcare Services Inc (AMN) United States $2.133B 6.90
BrightSpring Health Services (BTSG) United States $1.762B 0.00
Establishment Labs Holdings (ESTA) $1.444B 0.00
Agiliti (AGTI) United States $1.366B 22.31
NovoCure (NVCR) Jersey $1.297B 0.00
Alignment Healthcare (ALHC) United States $0.964B 0.00
Pediatrix Medical (MD) United States $0.740B 7.66
Embecta (EMBC) United States $0.596B 3.94
Auna S.A (AUNA) Luxembourg $0.549B 0.00
InnovAge Holding (INNV) United States $0.544B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.522B 0.00
Enhabit (EHAB) United States $0.507B 45.96
MultiPlan (MPLN) United States $0.475B 0.00
Beauty Health (SKIN) United States $0.423B 0.00
CareDx (CDNA) United States $0.418B 0.00
LifeMD (LFMD) United States $0.412B 0.00
Sonida Senior Living (SNDA) United States $0.391B 0.00
DocGo (DCGO) United States $0.356B 57.00
Sera Prognostics (SERA) United States $0.317B 0.00
ModivCare (MODV) United States $0.286B 3.79
Ascend Wellness Holdings (AAWH) United States $0.269B 0.00
GeneDx Holdings (WGS) United States $0.249B 0.00
Sharecare (SHCR) United States $0.227B 0.00
Biodesix (BDSX) United States $0.121B 0.00
So-Young (SY) China $0.119B 40.00
Oncology Institute (TOI) United States $0.091B 0.00
Pono Capital Two (PTWO) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
NeueHealth (NEUE) United States $0.052B 0.00
Co-Diagnostics (CODX) United States $0.036B 0.00
Nutex Health (NUTX) United States $0.033B 0.00
SeaStar Medical Holding (ICU) United States $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Singular Genomics Systems (OMIC) United States $0.029B 0.00
OncoCyte (OCX) United States $0.021B 0.00
DermTech (DMTK) United States $0.020B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.015B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
TRxADE HEALTH (MEDS) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
OpGen (OPGN) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Assure Holdings (IONM) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00